tiprankstipranks
Molecular Partners AG (CH:MOLN)
:MOLN

Compare Molecular Partners AG (MOLN) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
CHF3.41
CHF137.27M
-2.50
11.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.50
CHF867.56M
-8.17
239.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.88
CHF309.59M
-9.69
141.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF16.70
CHF237.10M
-0.98
31.50%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.50
CHF124.00M
3.99
9.69%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:MOLN
Molecular Partners AG
3.40
0.31
10.03%
CH:IDIA
Idorsia Ltd
3.43
2.43
244.03%
CH:NWRN
Newron Pharmaceuticals SpA
14.88
8.66
139.23%
CH:SANN
Santhera Pharmaceuticals Holding
16.70
3.44
25.94%
CH:RLF
CH:XLS
Xlife Sciences Ltd.
21.50
2.50
13.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts